FABBRIZI, EMANUELE
FABBRIZI, EMANUELE
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
Activation and inhibition of sirtuins: From bench to bedside
2024 Fiorentino, Francesco; Fabbrizi, Emanuele; Mai, Antonello; Rotili, Dante
An amazing 30-year journey around the DABO family. A medicinal chemistry lesson on a versatile class of non-nucleoside HIV-1 reverse transcriptase inhibitors
2025 Fabbrizi, Emanuele; Chernyshov, Vladimir V.; Fiorentino, Francesco; Sbardella, Gianluca; Ragno, Rino; Nawrozkij, Maxim; Ivanov, Roman; Rotili, Dante; Mai, Antonello
Chemical Modulation of the Epigenetic Network: Targeting Writers, Erasers, and Readers
2025 Fabbrizi, Emanuele
Development of C646‐based proteolysis targeting chimeras degraders of the lysine acetyltransferases CBP and p300
2025 Fiorentino, Francesco; Spriano, Filippo; Tomaselli, Daniela; Risi, Giorgia; Fabbrizi, Emanuele; Pecci, Valeria; Nanni, Simona; Bertoni, Francesco; Rotili, Dante; Mai, Antonello
Emerging roles of SIRT5 in metabolism, cancer, and SARS-CoV-2 infection
2023 Fabbrizi, Emanuele; Fiorentino, Francesco; Carafa, Vincenzo; Altucci, Lucia; Mai, Antonello; Rotili, Dante
Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation
2025 Fabbrizi, Emanuele; Fiorentino, Francesco; Casano, Fabrizio; Mai, Antonello; Rotili, Dante
Sirtuin modulators: a review of patents from 2020 to 2024
2025 Fabbrizi, Emanuele; Fiorentino, Francesco; Mai, Antonello; Rotili, Dante
Successes and challenges in the development of BD1-selective BET inhibitors. A patent review
2024 Viviano, Monica; Cipriano, Alessandra; Fabbrizi, Emanuele; Feoli, Alessandra; Castellano, Sabrina; Sbardella, Gianluca; Mai, Antonello; Milite, Ciro; Rotili, Dante
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development
2024 Appetecchia, Federico; Fabbrizi, Emanuele; Fiorentino, Francesco; Consalvi, Sara; Biava, Mariangela; Poce, Giovanna; Rotili, Dante
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni
2025 Fabbrizi, Emanuele; Hailu, Gebremedhin Solomon; Ganesan, A.; Fioravanti, Rossella; Zwergel, Clemens; Lambona, Chiara; Valente, Sergio; Fianco, Giulia; Iuzzolino, Angela; Trisciuoglio, Daniela; Caroli, Jonatan; Mattevi, Andrea; Häberli, Cécile; Keiser, Jennifer; Rotili, Dante; Mai, Antonello
Uracil- and Pyridine-containing HDAC inhibitors displayed cytotoxicity in colorectal and glioblastoma cancer stem cells
2024 Fiorentino, Francesco; Fabbrizi, Emanuele; Raucci, Alessia; Noce, Beatrice; Fioravanti, Rossella; Valente, Sergio; Paolini, Chantal; De Maria, Ruggero; Steinkühler, Christian; Gallinari, Paola; Rotili, Dante; Mai, Antonello
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activation and inhibition of sirtuins: From bench to bedside | 2024 | Fiorentino, Francesco; Fabbrizi, Emanuele; Mai, Antonello; Rotili, Dante | |
| An amazing 30-year journey around the DABO family. A medicinal chemistry lesson on a versatile class of non-nucleoside HIV-1 reverse transcriptase inhibitors | 2025 | Fabbrizi, Emanuele; Chernyshov, Vladimir V.; Fiorentino, Francesco; Sbardella, Gianluca; Ragno, Rino; Nawrozkij, Maxim; Ivanov, Roman; Rotili, Dante; Mai, Antonello | |
| Chemical Modulation of the Epigenetic Network: Targeting Writers, Erasers, and Readers | 2025 | Fabbrizi, Emanuele | |
| Development of C646‐based proteolysis targeting chimeras degraders of the lysine acetyltransferases CBP and p300 | 2025 | Fiorentino, Francesco; Spriano, Filippo; Tomaselli, Daniela; Risi, Giorgia; Fabbrizi, Emanuele; Pecci, Valeria; Nanni, Simona; Bertoni, Francesco; Rotili, Dante; Mai, Antonello | |
| Emerging roles of SIRT5 in metabolism, cancer, and SARS-CoV-2 infection | 2023 | Fabbrizi, Emanuele; Fiorentino, Francesco; Carafa, Vincenzo; Altucci, Lucia; Mai, Antonello; Rotili, Dante | |
| Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation | 2025 | Fabbrizi, Emanuele; Fiorentino, Francesco; Casano, Fabrizio; Mai, Antonello; Rotili, Dante | |
| Sirtuin modulators: a review of patents from 2020 to 2024 | 2025 | Fabbrizi, Emanuele; Fiorentino, Francesco; Mai, Antonello; Rotili, Dante | |
| Successes and challenges in the development of BD1-selective BET inhibitors. A patent review | 2024 | Viviano, Monica; Cipriano, Alessandra; Fabbrizi, Emanuele; Feoli, Alessandra; Castellano, Sabrina; Sbardella, Gianluca; Mai, Antonello; Milite, Ciro; Rotili, Dante | |
| Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development | 2024 | Appetecchia, Federico; Fabbrizi, Emanuele; Fiorentino, Francesco; Consalvi, Sara; Biava, Mariangela; Poce, Giovanna; Rotili, Dante | |
| Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni | 2025 | Fabbrizi, Emanuele; Hailu, Gebremedhin Solomon; Ganesan, A.; Fioravanti, Rossella; Zwergel, Clemens; Lambona, Chiara; Valente, Sergio; Fianco, Giulia; Iuzzolino, Angela; Trisciuoglio, Daniela; Caroli, Jonatan; Mattevi, Andrea; Häberli, Cécile; Keiser, Jennifer; Rotili, Dante; Mai, Antonello | |
| Uracil- and Pyridine-containing HDAC inhibitors displayed cytotoxicity in colorectal and glioblastoma cancer stem cells | 2024 | Fiorentino, Francesco; Fabbrizi, Emanuele; Raucci, Alessia; Noce, Beatrice; Fioravanti, Rossella; Valente, Sergio; Paolini, Chantal; De Maria, Ruggero; Steinkühler, Christian; Gallinari, Paola; Rotili, Dante; Mai, Antonello |